PDF Cover

Incentive Spirometer Market

The market for Incentive Spirometer was estimated at $480 million in 2023; it is anticipated to increase to $997 million by 2030, with projections indicating growth to around $1.68 billion by 2035.

Report ID:DS1801005
Author:Debadatta Patel - Senior Consultant
Published Date:
Datatree
Life Science
Medical Device
Incentive Spirometer
Share
Report Summary
Market Data
Methodology
Table of Contents

Global Incentive Spirometer Market Outlook

Revenue, 2023

$480M

Forecast, 2033

$1.36B

CAGR, 2024 - 2033

11%

The Incentive Spirometer industry revenue is expected to be around $532.8 million in 2024 and expected to showcase growth with 11% CAGR between 2024 and 2033. Building on this projected expansion, the incentive spirometer market holds increasing clinical significance within respiratory care and postoperative recovery management. Rising incidence of chronic respiratory diseases, growing surgical volumes, and heightened awareness of pulmonary rehabilitation are reinforcing steady demand. Healthcare providers are emphasizing preventive lung care to reduce postoperative complications such as atelectasis, particularly among elderly and high risk patients. Expanding hospital infrastructure in developing regions and stronger focus on home based respiratory therapy are further supporting adoption. In addition, lessons from recent global respiratory health crises have strengthened institutional focus on lung capacity monitoring and rehabilitation tools, ensuring sustained procurement across hospitals, ambulatory surgical centers, and long term care facilities.

An incentive spirometer is a handheld medical device designed to encourage deep breathing exercises to improve lung function and prevent pulmonary complications. It typically consists of a transparent chamber with visual volume indicators and a movable piston or ball that rises as the patient inhales. The device is widely used after surgeries, especially abdominal and thoracic procedures, to promote lung expansion and prevent fluid accumulation. It is also applied in chronic obstructive pulmonary disease management and pulmonary rehabilitation programs. Recent demand trends include the shift toward disposable and single patient devices to reduce infection risk, integration into home healthcare kits, and increased patient education initiatives that emphasize self managed respiratory therapy.

Incentive Spirometer market outlook with forecast trends, drivers, opportunities, supply chain, and competition 2023-2033
Incentive Spirometer Market Outlook

Market Key Insights

  • The Incentive Spirometer market is projected to grow from $480.0 million in 2023 to $1.36 billion in 2033. This represents a CAGR of 11%, reflecting rising demand across Postoperative Recovery, Chronic Respiratory Conditions, and Pulmonary Rehabilitation.

  • Teleflex, Smiths Medical, Cardinal Health are among the leading players in this market, shaping its competitive landscape.

  • U.S. and Germany are the top markets within the Incentive Spirometer market and are expected to observe the growth CAGR of 8.0% to 11.6% between 2023 and 2030.

  • Emerging markets including India, Brazil and Mexico are expected to observe highest growth with CAGR ranging between 10.6% to 13.8%.

  • Transition like Transition Toward Digital and Connected Respiratory Monitoring Solutions is expected to add $132 million to the Incentive Spirometer market growth by 2030.

  • The Incentive Spirometer market is set to add $883 million between 2023 and 2033, with manufacturer targeting Chronic Respiratory Conditions & Pulmonary Rehabilitation Application projected to gain a larger market share.

  • With

    increasing prevalence of respiratory diseases, and

    Growth in Postoperative Care Demand, Incentive Spirometer market to expand 184% between 2023 and 2033.

incentive spirometer market size with pie charts of major and emerging country share, CAGR, trends for 2025 and 2032
Incentive Spirometer - Country Share Analysis

Opportunities in the Incentive Spirometer

The integration of incentive spirometers with digital health platforms offers a key growth avenue, particularly in regions pushing telemedicine adoption. Smart spirometers that sync with mobile applications provide real-time metrics, adherence tracking, and remote clinician oversight, enhancing respiratory rehabilitation and chronic disease management. This trend is also gaining traction in Asia Pacific and Latin America, where healthcare providers are investing in connected care solutions. Digital devices capable of capturing inspiratory data and facilitating virtual care pathways are emerging as preferred tools in modern respiratory therapy.

Growth Opportunities in North America and Asia-Pacific

The North America incentive spirometer market is driven by high surgical volumes, strong chronic respiratory disease prevalence, and widespread adoption of preventive pulmonary care protocols. Advanced healthcare infrastructure and growing telehealth integration support demand for digital and connected spirometry devices. Key opportunities lie in home care settings and value-added post discharge respiratory monitoring solutions. Competitive intensity is moderate to high due to well-established medical device players and emerging digital health startups. Reimbursement support and patient awareness further strengthen buyer confidence, while product differentiation through smart features remains a critical success factor.
In Asia Pacific, expanding healthcare access, rising surgical procedures, and increasing respiratory disease burden are key drivers for the incentive spirometer market. Growth is particularly strong in China, India, and Southeast Asia as hospitals upgrade pulmonary care protocols and outpatient services expand. Opportunities exist in affordable, portable spirometers tailored to emerging market price sensitivity. Competition is fragmented with local manufacturers and international brands vying for share, placing emphasis on cost competitiveness and distribution networks. Rising health awareness and telemedicine adoption also support market momentum across the region.

Market Dynamics and Supply Chain

01

Driver: Rising Surgical Volumes and Growing Focus on Preventive Pulmonary Care Protocols

One of the primary drivers for the incentive spirometer market is also the increasing number of surgical procedures worldwide combined with an intensified focus on preventive pulmonary care to reduce postoperative complications. Growing healthcare access, especially in emerging economies, has also led to higher volumes of abdominal, thoracic, and cardiac surgeries where incentive spirometers are also standard tools for lung expansion therapy. Postoperative care teams rely on these devices to help patients perform deep breathing exercises, decrease the risk of atelectasis, and support faster recovery. Simultaneously, preventive pulmonary care protocols, driven by clinical guidelines and quality improvement initiatives, emphasize early intervention to maintain optimal lung function. Hospitals and surgical centers are also implementing structured respiratory therapy regimens that incorporate spirometers as a cost effective and noninvasive method. This combined trend not only enhances clinical outcomes but also reinforces institutional procurement, strengthening overall market demand for both traditional and advanced incentive spirometer models.
Another significant market driver is also the adoption of technological innovations such as digital incentive spirometers equipped with remote monitoring and data tracking capabilities. These smart devices allow clinicians and home care providers to monitor patient progress in real time, collect inspiratory volume metrics, and tailor therapy plans based on performance trends. Integration with mobile apps and cloud platforms enhances patient engagement and supports telehealth initiatives, particularly for chronic respiratory management. Digital spirometers also improve adherence by offering visual feedback, reminders, and progress alerts. As healthcare systems increasingly embrace digital health solutions, demand for advanced spirometry tools that offer connectivity and analytics is also rising, making this niche trend a key driver in modern respiratory care.
02

Restraint: Low Awareness and Inconsistent Adoption of Incentive Spirometry in Outpatient Settings

A significant restraint for the incentive spirometer market is limited awareness and inconsistent adoption outside hospital environments, particularly in outpatient and home care settings. Many patients and some healthcare providers remain unfamiliar with proper usage techniques and clinical benefits, reducing demand for home-based spirometers. For example, patients with chronic respiratory conditions may not receive adequate education on incorporating spirometry into daily therapy, leading to lower device utilization. This limits market expansion beyond institutional purchases and restricts revenue growth, especially in regions where outpatient pulmonary care protocols are less established or under-supported by healthcare systems.
03

Opportunity: Expanding Home Healthcare and Remote Respiratory Care Management Among Elderly Patients and Increasing Surgical Procedures in Asia Pacific Driving Postoperative Incentive Spirometer Adoption

The growing preference for home-based respiratory therapy among aging populations presents a significant opportunity for incentive spirometers. As elderly patients increasingly manage chronic conditions such as COPD and post-surgical recovery at home, demand for user-friendly, portable spirometers is rising. Telehealth adoption and remote patient monitoring further support this shift, enabling clinicians to track inspiratory performance outside traditional care settings. Volume-oriented and digital spirometers with connectivity features are especially positioned for growth in this segment. North America and Western Europe, with established home care networks, are expected to see the most rapid uptake.
Rapid expansion of surgical infrastructure in countries such as India, China, and Southeast Asian markets is generating demand for postoperative respiratory support devices. Growing volumes of abdominal, thoracic, and orthopedic surgeries create a need for incentive spirometers in both private and public hospitals. Clinicians in these regions are focusing on reducing postoperative pulmonary complications, making spirometers an essential component of recovery protocols. Affordable, durable models suited for high-volume clinical environments are expected to grow the most, capitalizing on expanding healthcare investments in Asia Pacific.
04

Challenge: Reimbursement Challenges and Cost Sensitivity Hinder Broader Market Penetration

Another key challenge is reimbursement variability and cost sensitivity among healthcare payers, which impacts procurement decisions and end-user demand. In countries with constrained healthcare budgets or limited insurance coverage for respiratory therapy devices, incentive spirometers may not be reimbursed or prioritized, pushing facilities to delay upgrades or opt for lower cost alternatives. For example, smaller clinics or home health providers might avoid stocking advanced digital spirometers due to higher upfront costs and unclear reimbursement pathways. This dynamic suppresses adoption rates and slows overall market revenue growth, particularly among premium and technologically advanced incentive spirometer models.

Supply Chain Landscape

1

Raw Material Supplier

BASFEastman
2

Device Manufacturer

TeleflexSmiths Medical
3

Distributor

McKessonCardinal Health
4

End-User

HospitalsClinicsHome care
Incentive Spirometer - Supply Chain

Use Cases of Incentive Spirometer in Postoperative Recovery & Chronic Respiratory Conditions

Postoperative Recovery : In Postoperative Recovery, incentive spirometers are primarily used in hospitals and surgical centers to prevent pulmonary complications such as atelectasis following abdominal, cardiac, or thoracic procedures. Volume oriented incentive spirometers are most commonly preferred in this setting because they provide measurable inspiratory volume targets, allowing clinicians to monitor patient progress accurately. Nurses and respiratory therapists instruct patients to perform controlled deep breathing exercises several times daily to promote lung expansion and improve oxygenation. Their visual feedback mechanism encourages patient participation, shortens recovery time, and reduces the risk of extended hospital stays, making them an essential component of postoperative care protocols.
Chronic Respiratory Conditions : In Chronic Respiratory Conditions, incentive spirometers are widely used in outpatient clinics and home healthcare environments for patients with conditions such as chronic obstructive pulmonary disease and asthma. Flow oriented spirometers are frequently utilized due to their simple design and ease of use for long term self management. These devices help patients strengthen respiratory muscles, enhance lung capacity, and maintain airway patency through regular breathing exercises. The portability and affordability of these spirometers support consistent at home therapy, reducing dependency on frequent hospital visits and improving overall disease management outcomes in chronic respiratory populations.
Pulmonary Rehabilitation : In Pulmonary Rehabilitation, incentive spirometers are integrated into structured rehabilitation programs conducted in specialty respiratory centers and community health facilities. Both volume oriented and digital spirometers are used, with digital variants gaining attention for offering enhanced monitoring and data tracking capabilities. Therapists guide patients through progressive breathing exercises designed to improve inspiratory strength and overall lung performance. These devices provide measurable benchmarks that help tailor individualized therapy plans. Their role in supporting long term respiratory recovery, particularly after severe infections or prolonged ventilation, continues to strengthen demand within rehabilitation services.

Recent Developments

Recent developments in the incentive spirometer market highlight the growing integration of digital respiratory monitoring tools and remote care support. Smart spirometers with connected health features are gaining traction as clinicians leverage mobile apps and cloud-based dashboards to track lung function outside hospital settings. A key market trend is the increasing emphasis on home pulmonary rehabilitation and telehealth, which is expanding demand beyond traditional postoperative use. These shifts are enhancing patient engagement, supporting preventive lung care, and creating new value in respiratory therapy services.

September 2024 : Teleflex launched a digital incentive spirometer with app connectivity for real-time patient feedback
July 2024 : Smiths Medical introduced an advanced incentive spirometer for improved postoperative care and patient comfort
April 2024 : Cardinal Health expanded its distribution network to increase accessibility of incentive spirometers in emerging markets

Impact of Industry Transitions on the Incentive Spirometer Market

As a core segment of the Medical Device industry, the Incentive Spirometer market develops in line with broader industry shifts. Over recent years, transitions such as Transition Toward Digital and Connected Respiratory Monitoring Solutions and Shift from Hospital Centered Use to Home Based Preventive Respiratory Care have redefined priorities across the Medical Device sector, influencing how the Incentive Spirometer market evolves in terms of demand, applications and competitive dynamics. These transitions highlight the structural changes shaping long-term growth opportunities.
01

Transition Toward Digital and Connected Respiratory Monitoring Solutions

The incentive spirometer industry is transitioning from basic mechanical breathing exercise devices to digital and connected respiratory monitoring solutions. Manufacturers are introducing smart spirometers with Bluetooth connectivity, mobile app integration, and cloud based data tracking to support remote patient monitoring. This shift aligns with the broader expansion of telehealth and home healthcare services. As a result, software developers and digital health platforms are increasingly collaborating with medical device companies to integrate spirometry data into virtual care ecosystems. The transition is also influencing the wearable health tech and remote diagnostics industries, creating cross sector partnerships and new revenue streams centered on data driven respiratory therapy management.
02

Shift from Hospital Centered Use to Home Based Preventive Respiratory Care

Another key transition is the movement from exclusive hospital based postoperative use toward preventive and long term home respiratory care. Patients with chronic respiratory conditions are now encouraged to use incentive spirometers regularly outside clinical settings to maintain lung capacity and reduce readmissions. This shift has expanded distribution channels into pharmacies, online medical supply platforms, and direct to consumer sales. It has also impacted the home medical equipment industry, which is seeing increased demand for affordable, portable spirometers. Insurance providers and outpatient rehabilitation services are adapting care models to include self managed breathing therapy, reinforcing this broader structural transition.